Sunday, October 25, 2020
Home Life Style Health & Fitness Anti-Viral Drug Remdesivir Does Not Effect Hospitalized COVID Patients: WHO

Anti-Viral Drug Remdesivir Does Not Effect Hospitalized COVID Patients: WHO

Remdesivir Drug is Not Helpful in Recovery of COVID Patients

Anti-viral drug Remdesivir has little or no effect in the recovery and mortality of hospitalized COVID-19 patients, said a World Health Organisation (WHO) study, giving a big blow to the hope that the drug from US-based Gilead Sciences raised in combating the pandemic.

The WHO said that the Solidarity Therapeutics Trial produced “conclusive evidence” on the effectiveness of repurposed drugs for COVID-19 in record time — just six months.

Interim results from the world’s largest randomized control trial on COVID-19 therapeutics have been uploaded as a preprint at medRxiv, the WHO said, adding that the results are under review for publication in a medical journal.

Follow NewsGram on Instagram to keep yourself updated.

The study, which spans more than 30 countries, looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalized patients.

Remdesivir
Anti-viral drug Remdesivir has little or no effect in the recovery and mortality of hospitalized Covid-19 patients, said a World Health Organisation. Unsplash

The results from the study indicate that Remdesivir, hydroxychloroquine, lopinavir/ritonavir, and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.

“These Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay,” said the study.

Also Read: Antibodies of Patients With Severe Covid-19 Affect Immune System: Study

The study conducted in 405 hospitals across 30 countries involved 11,266 adults.

Remdesivir was the only drug that received Emergency Use Authorisation for Covid-19 from the US Food and Drug Administration. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,779FollowersFollow

Most Popular

Indian Women Prone to More Aggressive Breast Cancer at Younger Age

In a major US study, researchers, including one of Indian-origin, have found that Indian and Pakistani women are diagnosed with breast cancer, including more...

How to Prepare a Successful Vacation Rental in 5 Easy Steps

Maximize your vacation rental by discovering essential steps for increasing bookings, providing a quality stay, and earning positive reviews.  Follow these 5 easy steps prepare...

Popular Games Millennials Are Playing Post Pubg Ban

While PlayerUnknown's Battlegrounds, popularly known as PUBG, is currently banned in India and despite several attempts by the game lovers to somehow play it...

B’Town Stars In Digital Edition Of Lakme Fashion Week

The digital edition of the Lakme Fashion Week saw B'Town stars like Sonakshi Sinha, Ishaan Khattar, Radhika Madan, Diana Penty, and Aparshakti Khurana turn...

Dussehra 2020: India Celebrates The Victory Of Good Over Evil With Vijaya Dashami

India is known as the land of festivals, and the festive season starts as soon as the calendar reaches October. One of the most...

Stars and Planets Grow Up Together, says Study

In a unique study, astronomers have found compelling evidence that the planets begin forming while stars are still infants and they grow up together...

Diana Penty Talks About Digitalizing Fashion Shows

In a day and age where most things are digital and everything has moved online, one would imagine the same to be the case...

New AI Predicts Risks of Developing Acute Kidney Injury

A new artificial-intelligence-based tool can help clinicians predict which hospitalized patients face a high risk of developing acute kidney injury (AKI), say, researchers, including...

Recent Comments